Table 1.

Pearson correlations between patient-rated IDS-SR₃₀ total score and clinician-rated depression measures, acute and continuation phases (ITT population).

Scale	Acute phase				Acute phase				Continuation phase
	Baseline				Week 10				Month 6
	n	Mean (S.D.)	r1	r2	n	Mean (S.D.)	r1	r2	n	Mean (S.D.)	r1	r2
IDS-SR₃₀ total	1026	43.06 (9.78)			785	17.37 (11.63)			435	12.32 (9.51)
QIDS-SR₁₆ total	1032	20.56 (5.50)			786	8.06 (5.60)			436	5.71 (4.57)
HAM-D₁₇ total	1047	22.64 (3.11)	0.46^*	0.43^*	789	7.32 (4.96)	0.75^*	0.73^*	435	4.86 (3.94)	0.70^*	0.66^*
CGI-S	1045	4.28 (0.56)	0.28^*	0.27^*	785	2.00 (0.97)	0.67^*	0.63^*	434	1.50 (0.78)	0.65^*	0.63^*
CGI-C	-	-	-		785	1.61 (0.82)	0.60^*	0.58^*	-	-	-

CGI-C, Clinical Global Impressions—Change; CGI-S, Clinical Global Impressions—Severity; HAM-D₁₇, 17-item Hamilton Rating Scale for Depression; IDS-SR₃₀, 30-item Inventory of Depressive Symptomatology—Self-Report; ITT, intent-to-treat; S.D., standard deviation; r1, Pearson correlation coefficient of scales with IDS-SR₃₀ total; r2, Pearson correlation coefficient of scales with QIDS-SR₁₆ total.

P<0.0001.